• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄相关的临床特征、病毒载量和疾病严重程度在小儿呼吸道合胞病毒感染中的相互作用。

Age-dependent Interactions Among Clinical Characteristics, Viral Loads and Disease Severity in Young Children With Respiratory Syncytial Virus Infection.

机构信息

From the Center for Vaccines and Immunity.

Biostatistics Core, Abigail Wexner Research Institute at Nationwide Children's Hospital.

出版信息

Pediatr Infect Dis J. 2021 Feb 1;40(2):116-122. doi: 10.1097/INF.0000000000002914.

DOI:10.1097/INF.0000000000002914
PMID:33433159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7808270/
Abstract

BACKGROUND

Age-dependent differences in clinical presentation and viral loads in infants and young children with respiratory syncytial virus (RSV) infection, and their correlation with disease severity are poorly defined.

METHODS

Previously healthy children <2 years old with mild (outpatients) and severe (inpatients) RSV infection were enrolled and viral loads measured by polymerase chain reaction in nasopharyngeal swabs. Patients were stratified by age in 0-<3, 3-6 and >6-24 months, and multivariable analyses were performed to identify clinical and viral factors associated with severe disease.

RESULTS

From 2014 to 2018, we enrolled 534 children with RSV infection, 130 outpatients with mild RSV infection and 404 inpatients with severe RSV disease. Median duration of illness was 4 days for both groups, yet viral loads were higher in outpatients than in inpatients (P < 0.001). In bivariate analyses, wheezing was more frequent in outpatients of older age (>3 months) than in inpatients (P < 0.01), while fever was more common in inpatients than outpatients (P < 0.01) and its frequency increased with age. Adjusted analyses confirmed that increased work of breathing and fever were consistently associated with hospitalization irrespective of age, while wheezing in infants >3 months, and higher RSV loads in children >6-24 months were independently associated with reduced disease severity.

CONCLUSIONS

Age had a significant impact defining the interactions among viral loads, specific clinical manifestations and disease severity in children with RSV infection. These observations highlight the importance of patient stratification when evaluating interventions against RSV.

摘要

背景

呼吸道合胞病毒(RSV)感染婴幼儿临床表现和病毒载量随年龄的变化及其与疾病严重程度的相关性尚不清楚。

方法

本研究纳入了年龄<2 岁的既往健康的轻(门诊)和重(住院)度 RSV 感染患儿,通过聚合酶链反应检测鼻咽拭子中的病毒载量。根据年龄将患者分为 0-<3 个月、3-6 个月和>6-24 个月三个亚组,采用多变量分析确定与重症疾病相关的临床和病毒因素。

结果

2014 年至 2018 年,共纳入 534 例 RSV 感染患儿,其中 130 例为门诊轻度 RSV 感染患儿,404 例为住院重度 RSV 疾病患儿。两组的疾病持续时间中位数均为 4 天,但门诊患儿的病毒载量高于住院患儿(P<0.001)。在单变量分析中,年龄较大(>3 个月)的门诊患儿比住院患儿更常出现喘息(P<0.01),而发热在住院患儿中比门诊患儿更常见(P<0.01),且其频率随年龄增加而增加。调整分析证实,呼吸做功增加和发热与住院治疗始终相关,而 3 个月以上婴儿的喘息以及 6-24 个月以上儿童的 RSV 载量更高与疾病严重程度降低相关。

结论

年龄对 RSV 感染患儿的病毒载量、特定临床表现和疾病严重程度之间的相互作用有显著影响。这些观察结果强调了在评估针对 RSV 的干预措施时,对患者进行分层的重要性。

相似文献

1
Age-dependent Interactions Among Clinical Characteristics, Viral Loads and Disease Severity in Young Children With Respiratory Syncytial Virus Infection.年龄相关的临床特征、病毒载量和疾病严重程度在小儿呼吸道合胞病毒感染中的相互作用。
Pediatr Infect Dis J. 2021 Feb 1;40(2):116-122. doi: 10.1097/INF.0000000000002914.
2
Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analyses.帕利珠单抗预防高危婴儿和幼儿呼吸道合胞病毒(RSV)毛细支气管炎的免疫预防作用:亚组分析的系统评价和额外的经济建模。
Health Technol Assess. 2011 Jan;15(5):iii-iv, 1-124. doi: 10.3310/hta15050.
3
A systematic review of compliance with palivizumab administration for RSV immunoprophylaxis.对帕利珠单抗用于呼吸道合胞病毒免疫预防给药依从性的系统评价。
J Manag Care Pharm. 2010 Jan-Feb;16(1):46-58. doi: 10.18553/jmcp.2010.16.1.46.
4
Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children.帕利珠单抗预防儿童严重呼吸道合胞病毒(RSV)感染。
Cochrane Database Syst Rev. 2021 Nov 16;11(11):CD013757. doi: 10.1002/14651858.CD013757.pub2.
5
Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection.免疫球蛋白治疗住院婴儿和幼儿呼吸道合胞病毒感染。
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD009417. doi: 10.1002/14651858.CD009417.pub3.
6
Epidemiology and clinical characteristics of respiratory syncytial virus infections among children and adults in Mexico.墨西哥儿童和成人呼吸道合胞病毒感染的流行病学及临床特征
Influenza Other Respir Viruses. 2017 Jan;11(1):48-56. doi: 10.1111/irv.12414. Epub 2016 Aug 18.
7
Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children.用于降低儿童呼吸道合胞病毒感染风险的单克隆抗体。
Cochrane Database Syst Rev. 2013 Apr 30(4):CD006602. doi: 10.1002/14651858.CD006602.pub4.
8
Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation.使用帕利珠单抗对儿童进行呼吸道合胞病毒(RSV)免疫预防:一项系统评价与经济学评估
Health Technol Assess. 2008 Dec;12(36):iii, ix-x, 1-86. doi: 10.3310/hta12360.
9
Risk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years: Systematic review and meta-analysis.五岁以下儿童呼吸道合胞病毒相关急性下呼吸道感染的危险因素:系统评价与荟萃分析
J Glob Health. 2015 Dec;5(2):020416. doi: 10.7189/jogh.05.020416.
10
Lower respiratory tract co-infection of and respiratory syncytial virus shapes microbial landscape and clinical outcomes in children.副流感病毒与呼吸道合胞病毒的下呼吸道合并感染塑造了儿童的微生物格局和临床结局。
Front Cell Infect Microbiol. 2025 Jun 9;15:1593053. doi: 10.3389/fcimb.2025.1593053. eCollection 2025.

引用本文的文献

1
Young infants with bronchiolitis at low risk of respiratory deterioration in an urban, academic emergency department: prospective cohort study protocol.城市学术急诊科中呼吸恶化风险较低的毛细支气管炎婴幼儿:前瞻性队列研究方案
BMJ Open. 2025 Aug 26;15(8):e101880. doi: 10.1136/bmjopen-2025-101880.
2
Respiratory Syncytial Virus: A Narrative Review of Updates and Recent Advances in Epidemiology, Pathogenesis, Diagnosis, Management and Prevention.呼吸道合胞病毒:流行病学、发病机制、诊断、治疗与预防的最新进展及近期研究综述
J Clin Med. 2025 May 30;14(11):3880. doi: 10.3390/jcm14113880.
3
Bronchiolitis Severity Affects Blood Count and Inflammatory Marker Levels: A Real-Life Experience.

本文引用的文献

1
Immune profiles provide insights into respiratory syncytial virus disease severity in young children.免疫特征可深入了解婴幼儿呼吸道合胞病毒疾病的严重程度。
Sci Transl Med. 2020 Apr 22;12(540). doi: 10.1126/scitranslmed.aaw0268.
2
The journey to a respiratory syncytial virus vaccine.呼吸道合胞病毒疫苗研发之旅。
Ann Allergy Asthma Immunol. 2020 Jul;125(1):36-46. doi: 10.1016/j.anai.2020.03.017. Epub 2020 Mar 23.
3
Factors Contributing to Symptom Duration and Viral Reduction in Outpatient Children With Respiratory Syncytial Virus Infection.
细支气管炎严重程度影响血细胞计数和炎症标志物水平:一项真实病例经验
Viruses. 2025 Jan 9;17(1):77. doi: 10.3390/v17010077.
4
Inhibition, transition, and surge: dynamic evolution of pediatric respiratory pathogen trends amid COVID-19 pandemic policy adjustments.抑制、转变和激增:COVID-19 大流行政策调整期间儿科呼吸道病原体趋势的动态演变。
Front Public Health. 2024 Aug 22;12:1420929. doi: 10.3389/fpubh.2024.1420929. eCollection 2024.
5
Exploring Ribosomal Genes as Potential Biomarkers of the Immune Microenvironment in Respiratory Syncytial Virus Infection.探索核糖体基因作为呼吸道合胞病毒感染中免疫微环境的潜在生物标志物
Biochem Genet. 2025 Apr;63(2):1839-1861. doi: 10.1007/s10528-024-10778-6. Epub 2024 Apr 17.
6
Characteristics of Respiratory Syncytial Virus Infections in Children in the Post-COVID Seasons: A Northern Italy Hospital Experience.后 COVID 季节儿童呼吸道合胞病毒感染的特征:意大利北部医院的经验。
Viruses. 2024 Jan 16;16(1):126. doi: 10.3390/v16010126.
7
An overview on viral interference during SARS-CoV-2 pandemic.2019冠状病毒病大流行期间病毒干扰概述。
Front Pediatr. 2023 Dec 21;11:1308105. doi: 10.3389/fped.2023.1308105. eCollection 2023.
8
Age and respiratory syncytial virus etiology in bronchiolitis clinical outcomes.毛细支气管炎临床结局中的年龄与呼吸道合胞病毒病因
J Allergy Clin Immunol Glob. 2022 Jul 14;1(3):91-98. doi: 10.1016/j.jacig.2022.05.005. eCollection 2022 Aug.
9
Clinical characteristics of children with omicron SARS-CoV-2 infection in Changchun, China from march to april 2022: A retrospective study.2022年3月至4月中国长春儿童感染奥密克戎变异株新冠病毒的临床特征:一项回顾性研究
Front Pediatr. 2022 Nov 15;10:990944. doi: 10.3389/fped.2022.990944. eCollection 2022.
10
Cytokine expression in rhinovirus- vs. respiratory syncytial virus-induced first wheezing episode and its relation to clinical course.病毒诱导的首次喘息发作中细胞因子的表达及其与临床过程的关系。
Front Immunol. 2022 Nov 14;13:1044621. doi: 10.3389/fimmu.2022.1044621. eCollection 2022.
门诊呼吸道合胞病毒感染患儿症状持续时间和病毒减少的相关因素。
Pediatr Infect Dis J. 2020 Aug;39(8):678-683. doi: 10.1097/INF.0000000000002626.
4
Association of Viral Load With Disease Severity in Outpatient Children With Respiratory Syncytial Virus Infection.门诊呼吸道合胞病毒感染儿童病毒载量与疾病严重程度的关联
J Infect Dis. 2020 Jun 29;222(2):298-304. doi: 10.1093/infdis/jiaa076.
5
Factors predicting length of stay in bronchiolitis.毛细支气管炎住院时间的预测因素。
Respir Med. 2020 Jan;161:105824. doi: 10.1016/j.rmed.2019.105824. Epub 2019 Nov 16.
6
Severe Respiratory Syncytial Virus Infection in Hospitalized Children.严重呼吸道合胞病毒感染住院患儿。
Arch Med Res. 2019 Aug;50(6):377-383. doi: 10.1016/j.arcmed.2019.10.005. Epub 2019 Oct 31.
7
Assessment and Validation of Syndromic Case Definitions for Respiratory Syncytial Virus Infections in Young Infants: A Latent Class Analysis.评估和验证用于婴幼儿呼吸道合胞病毒感染的综合征病例定义:潜在类别分析。
Pediatr Infect Dis J. 2019 Dec;38(12):1177-1182. doi: 10.1097/INF.0000000000002468.
8
Infant Immune Response to Respiratory Viral Infections.婴儿对呼吸道病毒感染的免疫反应。
Immunol Allergy Clin North Am. 2019 Aug;39(3):361-376. doi: 10.1016/j.iac.2019.03.005. Epub 2019 May 15.
9
Viral Load Dynamics and Clinical Disease Severity in Infants With Respiratory Syncytial Virus Infection.呼吸道合胞病毒感染婴儿的病毒载量动态和临床疾病严重程度。
J Infect Dis. 2019 Apr 8;219(8):1207-1215. doi: 10.1093/infdis/jiy655.
10
Fever Responses Are Enhanced with Advancing Age during Respiratory Syncytial Virus Infection among Children under 24 Months Old.在24个月以下儿童感染呼吸道合胞病毒期间,发热反应会随着年龄增长而增强。
Tohoku J Exp Med. 2018 Jul;245(3):217-222. doi: 10.1620/tjem.245.217.